Roche Holding AG (LON: 0TDF)

London flag London · Delayed Price · Currency is GBP · Price in USD
34.45
-1.66 (-4.60%)
Dec 19, 2024, 2:31 PM BST
-2.05%
Market Cap 176.69B
Revenue (ttm) 53.35B
Net Income (ttm) 9.35B
Shares Out n/a
EPS (ttm) 11.66
PE Ratio 18.90
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100
Open 34.45
Previous Close 36.11
Day's Range 34.45 - 34.45
52-Week Range 29.35 - 41.85
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Jan 31, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, d... [Read more]

Industry Pharmaceutical Preparations
Founded 1896
Employees 103,605
Stock Exchange London Stock Exchange
Ticker Symbol 0TDF
Full Company Profile

Financial Performance

In 2023, Roche Holding AG's revenue was 60.44 billion, a decrease of -8.16% compared to the previous year's 65.81 billion. Earnings were 11.50 billion, a decrease of -7.43%.

Financial numbers in CHF Financial Statements

News

There is no news available yet.